Back to Search
Start Over
Effects of sleep deprivation on inhibitory biomarkers of schizophrenia: implications for drug development.
- Source :
-
The lancet. Psychiatry [Lancet Psychiatry] 2015 Nov; Vol. 2 (11), pp. 1028-35. - Publication Year :
- 2015
-
Abstract
- Development of drugs for the treatment of the clinical symptoms and cognitive deficits of schizophrenia is unsatisfactory, with many initially promising compounds not showing beneficial effects in clinical studies. Experimental model systems of schizophrenia combined with well-validated biomarkers are urgently needed to provide early indicators of effectiveness. Herein, we argue that experimentally controlled sleep deprivation represents a translational model system that can be studied in combination with neurocognitive biomarkers. Specifically, we review data on the psychotomimetic effects of sleep deprivation in healthy human beings and provide evidence of the psychosis-like deficits in translational inhibitory biomarkers-prepulse inhibition and antisaccades-that occur after sleep deprivation. These data support the use of the sleep deprivation model in combination with biomarkers with excellent psychometric properties and well-characterised neural mechanisms, such as prepulse inhibition and antisaccades, to substantially advance development of drugs with antipsychotic or pro-cognitive effects.<br /> (Copyright © 2015 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2215-0374
- Volume :
- 2
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- The lancet. Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 26544751
- Full Text :
- https://doi.org/10.1016/S2215-0366(15)00313-2